# Defining Cannabis Use Disorder in Administrative Health Data: A Systematic Review of Case Definitions and Validation Approaches. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-use-disorder-administrative-data-validation-systematic-review/ > **Published:** 2026-04-27T22:23:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:00:30-04:00 > **Clinical Summary:** Systematic review reveals serious reliability problems with cannabis use disorder identification in administrative health data due to inconsistent coding practi --- CED Clinical Relevance  #76Notable Clinical Interest Evidence Brief | CED ClinicSystematic review reveals inconsistent diagnostic coding practices for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) across administrative health databases, undermining research comparability and clinical surveillance accuracy. [Cannabis Use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) DisorderAdministrative DataDiagnostic CodingEpidemiologySystematic Review Systematic review reveals inconsistent diagnostic coding practices for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) across administrative health databases, undermining research comparability and clinical surveillance accuracy. What This Study Teaches Us This review exposes fundamental inconsistencies in how [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) disorder is identified and coded across health systems. The variation in diagnostic coding practices creates a measurement problem that compromises our ability to track CUD prevalence, outcomes, and healthcare utilization patterns reliably. Why This Matters Clinicians and policymakers rely on administrative data to understand cannabis use disorder patterns, allocate resources, and evaluate interventions. Without standardized case definitions, we cannot trust that reported CUD rates reflect actual clinical reality or compare findings across different health systems meaningfully. Study Snapshot Study Type Systematic Review Population 56 studies using administrative health data to identify cannabis use disorder Intervention Various case definition approaches using ICD-9/ICD-10 diagnostic codes Comparator Different coding strategies and validation methods across studies Primary Outcome Operational definitions and validation practices for cannabis use disorder identification Key Finding Most studies used one-or-more-code rule with ICD codes, but operational details varied significantly by jurisdiction and framework Journal Cannabis and [Cannabinoid Research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) Year 2024 Clinical Bottom Line The lack of validated, standardized case definitions for cannabis use disorder in administrative databases means current epidemiologic estimates may be unreliable. Clinicians should interpret population-level CUD data with significant caution until measurement practices are harmonized. What This Paper Does Not Show This review does not provide actual prevalence data for cannabis use disorder or demonstrate which case definition approach is most accurate. It also does not address how coding practices might differ between different clinical settings or provider types. Where This Paper Deserves Skepticism The review’s scope may have missed important coding variations in newer health information systems or specialized [addiction treatment](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) databases. Additionally, the authors had limited ability to assess the clinical accuracy of the various case definitions without validation against clinical gold standards. Dr. Caplan's Take This confirms what I’ve suspected in clinical practice—our surveillance systems for cannabis use disorder are fundamentally broken. I regularly see patients with clear CUD who aren’t coded appropriately, while others receive CUD diagnoses that seem clinically questionable. Until we fix the measurement problem, our epidemiologic understanding remains compromised. What a Careful Reader Should Take Away Administrative health data on cannabis use disorder should be interpreted with extreme caution due to inconsistent case definition practices. Current population estimates of CUD prevalence and trends may not reflect clinical reality, and cross-jurisdictional comparisons are likely invalid. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Defining%20Cannabis%20Use%20Disorder%20in%20Administrative%20Health%20Data%3A%20A%20Systematic%20Review%20of%20Case%20Definition...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-disorder-administrative-data-validation-systematic-review%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-use-disorder-administrative-data-validation-systematic-review%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Defining%20Cannabis%20Use%20Disorder%20in%20Administrative%20Health%20Data%3A%20A%20Systematic%20Review%20of%20Case%20Definition...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fcannabis-use-disorder-administrative-data-validation-systematic-review%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Table of Contents - [FAQ](#FAQ)[How reliable are current administrative health databases for identifying cannabis use disorder cases?](#How_reliable_are_current_administrative_health_databases_for_identifying_cannabis_use_disorder_cases) - [What diagnostic coding systems are most commonly used to identify cannabis use disorder in health records?](#What_diagnostic_coding_systems_are_most_commonly_used_to_identify_cannabis_use_disorder_in_health_records) - [Why should clinicians be concerned about inconsistent cannabis use disorder coding practices?](#Why_should_clinicians_be_concerned_about_inconsistent_cannabis_use_disorder_coding_practices) - [How do variations in diagnostic coding affect cannabis use disorder research comparability?](#How_do_variations_in_diagnostic_coding_affect_cannabis_use_disorder_research_comparability) - [What steps can healthcare systems take to improve cannabis use disorder case identification accuracy?](#What_steps_can_healthcare_systems_take_to_improve_cannabis_use_disorder_case_identification_accuracy) - [Related](#Related) ## FAQ #### How reliable are current administrative health databases for identifying cannabis use disorder cases? Current administrative health databases show significant variability in diagnostic coding practices for cannabis use disorder, which undermines the reliability of case identification. This systematic review of 56 studies found inconsistent operational definitions across different jurisdictions and coding frameworks, with most studies lacking proper validation of their case definitions. #### What diagnostic coding systems are most commonly used to identify cannabis use disorder in health records? Most studies rely on ICD-9 or ICD-10 diagnostic codes to identify cannabis use disorder cases. The typical approach uses a “one-or-more-code rule,” though specific implementation varies significantly by healthcare system, jurisdiction, and the observation window used for case identification. #### Why should clinicians be concerned about inconsistent cannabis use disorder coding practices? Inconsistent coding practices limit the ability to accurately track [cannabis use disorder prevalence](https://cedclinic.com/cannabis-use-insomnia-patients-sleep-benefits/) and treatment outcomes across different healthcare systems. This affects epidemiologic surveillance, health services research, and policy evaluation, potentially leading to inadequate resource allocation and treatment planning. #### How do variations in diagnostic coding affect cannabis use disorder research comparability? The lack of standardized case definitions makes it difficult to compare cannabis use disorder rates and treatment effectiveness across different studies and healthcare systems. This variation in coding strategies and observation windows undermines the validity of meta-analyses and systematic reviews in this field. #### What steps can healthcare systems take to improve cannabis use disorder case identification accuracy? Healthcare systems should implement standardized case definitions with validated diagnostic criteria and establish consistent coding practices across all care settings. Regular validation studies comparing administrative data with clinical assessments are essential to ensure accurate case identification and improve surveillance quality. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).